<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/11/PT-24-11-2025-shutterstock_1958741605-430x241.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/11/PT-24-11-2025-shutterstock_1958741605-430x241.jpg"/></p>
<p>阿斯利康在美国的运营包括 19 个地点和超过 25,000 名员工。图片来源：Grand Warszawski/Shutterstock.com。</p>
<p>阿斯利康宣布了一项 20 亿美元的投资计划，以扩大其在美国马里兰州的生物制造业务，旨在支持弗雷德里克和盖瑟斯堡两个地点的 2,600 个工作岗位。</p>
<p>该投资涵盖了弗雷德里克生物制药制造设施的扩建以及在盖瑟斯堡新建工厂，目标是在 2029 年前实现运营准备。</p>
<h3>深入了解 GlobalData</h3>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>报告</p>
<h4>NPVM: 阿斯利康的 AZD-8205</h4>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>报告</p>
<h4>NPVM: 阿斯利康的 MEDI-7352</h4>
<h5>深入了解 GlobalData</h5>
<p>商业智能的黄金标准。</p>
<p>了解更多</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>发现高效的 B2B 营销</h4>
<p>结合商业智能和编辑卓越，接触到 36 个领先媒体平台上的专业人士。</p>
<p>了解更多</p>
<p>弗雷德里克工厂生产用于自身免疫、癌症、罕见疾病和呼吸系统治疗的生物制剂，计划扩建将几乎使其商业制造能力翻倍。</p>
<p>这将创造 900 个建筑岗位和 200 个技术岗位。</p>
<p>阿斯利康还将在盖瑟斯堡建立一座新的制造设施，以开发和供应用于临床试验的新分子。</p>
<p>该地点将支持 1,000 个与建筑相关的工作，创造 100 个新岗位，并保留 400 个现有岗位。</p>
<p><img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/></p>
<p>GlobalData 战略情报</p>
<h1>美国关税正在变化 - 你会反应还是预见？</h1>
<p>不要让政策变化让你措手不及。通过实时数据和专家分析保持主动。</p>
<p>来自 GlobalData</p>
<p>了解更多关于战略情报</p>
<p>这两个设施将利用数据分析、先进的人工智能和自动化，并将设计符合高环境标准。</p>
<p>阿斯利康首席执行官帕斯卡尔·索里奥表示：“今天标志着马里兰州和美国患者的一个里程碑时刻。作为该州最大的生物制药雇主，我们正在加深对马里兰州的长期承诺——支持 2,600 个工作岗位，催化经济增长，并首次将我们广泛的罕见疾病产品组合引入本土。</p>
<p>“这项投资增强了美国药品供应链的韧性，加速了患者在美国及全球获得变革性疗法的机会。”</p>
<p>最新的发展是阿斯利康于 2025 年 7 月宣布的 500 亿美元投资计划。</p>
<p>这项计划紧随公司在德克萨斯州科佩尔现有制造基地的扩建、在马里兰州罗克维尔新开设的细胞治疗制造工厂以及在弗吉尼亚州建立的新药物生产设施之后。</p>
<p>阿斯利康在美国的运营现在覆盖 19 个研发、商业和制造地点，雇佣超过 25,000 名员工，并支持 100,000 个工作岗位。2025 年，它为美国经济创造了 200 亿美元的价值。</p>
<h2>制药技术卓越奖 - 参赛的好处</h2>
<p>获得应有的认可！制药技术卓越奖 庆祝创新、领导力和影响力。通过参赛，您展示了自己的成就，提高了行业形象，并将自己定位于推动制药进步的顶尖领导者之中。不要错过脱颖而出的机会——今天就提交您的参赛作品！</p>
<p>立即提名</p>

阿斯利康

<p>阿斯利康宣布将在美国马里兰州投资 20 亿美元，以扩大其生物制造能力。该计划包括扩建弗雷德里克生物制药制造设施，并在盖瑟斯堡建设一座新工厂，支持 2600 个就业岗位。弗雷德里克工厂的产能将几乎翻倍，而盖瑟斯堡设施将开发用于临床试验的新分子。两个地点都将使用先进的人工智能和自动化技术。这项投资是阿斯利康在 2025 年宣布的 500 亿美元计划的一部分，旨在加强美国药品供应链并加速治疗方案的获取</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/11/PT-24-11-2025-shutterstock_1958741605-430x241.jpg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/11/PT-24-11-2025-shutterstock_1958741605-430x241.jpg"/></p>
<p>AstraZeneca’s US operations include 19 sites and more than 25,000 staff. Credit: Grand Warszawski/Shutterstock.com.</p>
<div class="lb-trans"><p>阿斯利康在美国的运营包括 19 个地点和超过 25,000 名员工。图片来源：Grand Warszawski/Shutterstock.com。</p>
</div><p>AstraZeneca has announced a $2bn investment plan to expand its biomanufacturing presence in the US state of Maryland, aiming to support 2,600 jobs at its Frederick and Gaithersburg sites.</p>
<div class="lb-trans"><p>阿斯利康宣布了一项 20 亿美元的投资计划，以扩大其在美国马里兰州的生物制造业务，旨在支持弗雷德里克和盖瑟斯堡两个地点的 2,600 个工作岗位。</p>
</div><p>The investment covers both expansion of the Frederick biologics manufacturing facility and a new plant construction in Gaithersburg, targeting operational readiness by 2029.</p>
<div class="lb-trans"><p>该投资涵盖了弗雷德里克生物制药制造设施的扩建以及在盖瑟斯堡新建工厂，目标是在 2029 年前实现运营准备。</p>
</div><h3>Go deeper with GlobalData</h3>
<div class="lb-trans"><h3>深入了解 GlobalData</h3>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>报告</p>
</div><h4>NPVM: AstraZeneca Plc's AZD-8205</h4>
<div class="lb-trans"><h4>NPVM: 阿斯利康的 AZD-8205</h4>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>报告</p>
</div><h4>NPVM: AstraZeneca Plc's MEDI-7352</h4>
<div class="lb-trans"><h4>NPVM: 阿斯利康的 MEDI-7352</h4>
</div><h5>Go deeper with GlobalData</h5>
<div class="lb-trans"><h5>深入了解 GlobalData</h5>
</div><p>The gold standard of business intelligence.</p>
<div class="lb-trans"><p>商业智能的黄金标准。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>了解更多</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>Discover B2B Marketing That Performs</h4>
<div class="lb-trans"><h4>发现高效的 B2B 营销</h4>
</div><p>Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.</p>
<div class="lb-trans"><p>结合商业智能和编辑卓越，接触到 36 个领先媒体平台上的专业人士。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>了解更多</p>
</div><p>The Frederick site, which produces biologics used in autoimmune, cancer, rare disease and respiratory treatments, will almost double its commercial manufacturing capacity through the planned expansion.</p>
<div class="lb-trans"><p>弗雷德里克工厂生产用于自身免疫、癌症、罕见疾病和呼吸系统治疗的生物制剂，计划扩建将几乎使其商业制造能力翻倍。</p>
</div><p>It will generate 900 construction roles and 200 skilled jobs.</p>
<div class="lb-trans"><p>这将创造 900 个建筑岗位和 200 个技术岗位。</p>
</div><p>AstraZeneca will also build a new manufacturing facility in Gaithersburg to develop and supply new molecules for use in clinical trials.</p>
<div class="lb-trans"><p>阿斯利康还将在盖瑟斯堡建立一座新的制造设施，以开发和供应用于临床试验的新分子。</p>
</div><p>This site will back 1,000 construction-related jobs, create 100 new jobs and retain 400 existing roles.</p>
<div class="lb-trans"><p>该地点将支持 1,000 个与建筑相关的工作，创造 100 个新岗位，并保留 400 个现有岗位。</p>
</div><p><img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/></p>
<p>GlobalData Strategic Intelligence</p>
<div class="lb-trans"><p>GlobalData 战略情报</p>
</div><h1>US Tariffs are shifting - will you react or anticipate?</h1>
<div class="lb-trans"><h1>美国关税正在变化 - 你会反应还是预见？</h1>
</div><p>Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.</p>
<div class="lb-trans"><p>不要让政策变化让你措手不及。通过实时数据和专家分析保持主动。</p>
</div><p>By GlobalData</p>
<div class="lb-trans"><p>来自 GlobalData</p>
</div><p>Learn more about Strategic Intelligence</p>
<div class="lb-trans"><p>了解更多关于战略情报</p>
</div><p>Both facilities will utilise data analytics, advanced AI and automation, and will be designed to comply with high environmental standards.</p>
<div class="lb-trans"><p>这两个设施将利用数据分析、先进的人工智能和自动化，并将设计符合高环境标准。</p>
</div><p>AstraZeneca CEO Pascal Soriot stated: “Today marks a landmark moment for Maryland and American patients. As the state’s largest biopharmaceutical employer, we are deepening our long-standing commitment to Maryland – supporting 2,600 jobs, catalysing economic growth and bringing our extensive rare disease portfolio onshore for the first time.</p>
<div class="lb-trans"><p>阿斯利康首席执行官帕斯卡尔·索里奥表示：“今天标志着马里兰州和美国患者的一个里程碑时刻。作为该州最大的生物制药雇主，我们正在加深对马里兰州的长期承诺——支持 2,600 个工作岗位，催化经济增长，并首次将我们广泛的罕见疾病产品组合引入本土。</p>
</div><p>“This investment strengthens the resilience of the US medicines supply chain and accelerates access to transformative therapies for patients across America and around the world.”</p>
<div class="lb-trans"><p>“这项投资增强了美国药品供应链的韧性，加速了患者在美国及全球获得变革性疗法的机会。”</p>
</div><p>The latest development is part of AstraZeneca’s $50bn investment initiative that was announced in July 2025.</p>
<div class="lb-trans"><p>最新的发展是阿斯利康于 2025 年 7 月宣布的 500 亿美元投资计划。</p>
</div><p>It follows the expansion of the company’s existing manufacturing site in Coppell, Texas, the opening of a new cell therapy manufacturing plant in Rockville, Maryland, and the establishment of a new drug substance production facility in Virginia.</p>
<div class="lb-trans"><p>这项计划紧随公司在德克萨斯州科佩尔现有制造基地的扩建、在马里兰州罗克维尔新开设的细胞治疗制造工厂以及在弗吉尼亚州建立的新药物生产设施之后。</p>
</div><p>AstraZeneca’s US operations now cover 19 research and development, commercial and manufacturing sites, employ more than 25,000 staff and support 100,000 jobs. In 2025, it created $20bn of value for the US economy.</p>
<div class="lb-trans"><p>阿斯利康在美国的运营现在覆盖 19 个研发、商业和制造地点，雇佣超过 25,000 名员工，并支持 100,000 个工作岗位。2025 年，它为美国经济创造了 200 亿美元的价值。</p>
</div><h2>Pharmaceutical Technology Excellence Awards - The Benefits of Entering</h2>
<div class="lb-trans"><h2>制药技术卓越奖 - 参赛的好处</h2>
</div><p>Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!</p>
<div class="lb-trans"><p>获得应有的认可！制药技术卓越奖 庆祝创新、领导力和影响力。通过参赛，您展示了自己的成就，提高了行业形象，并将自己定位于推动制药进步的顶尖领导者之中。不要错过脱颖而出的机会——今天就提交您的参赛作品！</p>
</div><p>Nominate Now</p>
<div class="lb-trans"><p>立即提名</p>
</div>

阿斯利康计划在美国马里兰州扩展其生物制造业务